Forecasting Art Coverage in Egypt Using Artificial Neural Networks

Dr. Smartson. P. NYONIZICHIRe Project, University of Zimbabwe, Harare, ZimbabweThabani NYONIDepartment of Economics, University of Zimbabwe, Harare, Zimbabwe

Vol 5 No 3 (2021): Volume 5, Issue 3, March 2021 | Pages: 156-160

International Research Journal of Innovations in Engineering and Technology

OPEN ACCESS | Research Article | Published Date: 31-03-2021

doi Logo doi.org/10.47001/IRJIET/2021.503027

Abstract
In this research article, the ANN approach was applied to analyze ART coverage in Egypt. The employed annual data covers the period 2000-2018 and the out-of-sample period ranges over the period 2019-2023. The residuals and forecast evaluation criteria (Error, MSE and MAE) of the applied model indicate that the model is stable in forecasting ART coverage in Egypt. The results of the study indicate that ART coverage will remain very low in Egypt over the period 2019-2023. The government is encouraged to intensify demand creation for HIV testing and ART services amongst other strategies.
Keywords

ANN, ART coverage, Forecasting.


Citation of this Article

Dr. Smartson. P. NYONI, Thabani NYONI, “Forecasting Art Coverage in Egypt Using Artificial Neural Networks” Published in International Research Journal of Innovations in Engineering and Technology - IRJIET, Volume 5, Issue 3, pp 156-160, March 2021. Article DOI https://doi.org/10.47001/IRJIET/2021.503027

References
  1. David P. Urassa., Sarah Matemu & Bruno F Sunguya (2018).Antiretroviral therapy clinic attendance among children aged 0-14 years in Kahama district, Tanzania: a cross-sectional study  Tanzania Journal of Health Research  Doi: http://dx.doi.org/10.4314/thrb.v20i1.8 Volume 20, Number 1, January 2018
  2. National HIV and AIDS Health Sector Research and Evaluation Agenda (2011 - 2015). National AIDS Control Program, Tanzania. NACP
  3. Rosen S & Fox MP (2011). Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med. 8(7): e1001056. https://doi.org/10.1371/journal.pmed.1001056 PMID: 21811403
  4. WHO (2016). Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. Geneva.
  5. WHO (2018). Access to antiretroviral and direct-acting antiviral medicines, and HIV diagnostics. 2016 update. WHO: Geneva.